Abstract
Objectives: to analyze and synthesize the available evidence on the effect of parental cannabis use on the risk of sudden infant death syndrome (SIDS).
Methods: a systematic review was conducted in PubMed/MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library, from inception to December 2023. The search terms included “marijuana,” “cannab*,” “Sudden Infant Death,” “Sudden Infant Death Syndrome,” “SIDS,” “Crib Death,” and “Cot Death.” Study selection was performed independently by two reviewers, with disagreements resolved by a third author.
Results: nine studies were included, all from developed countries. Statistical analyses specifically addressing the association between cannabis use and SIDS were available in seven studies, four of which suggested a positive association. However, limitations included the absence of detailed data on frequency, route, and intensity of cannabis use, with substantial variation in exposure assessment across studies, which hinders comparability.
Conclusions: Although there is evidence of an association between cannabis use and SIDS, methodological limitations prevent us from inferring causality. More robust research is needed to explore the mechanisms underlying cannabis use during pregnancy and postpartum by mothers and fathers in order to inform preventive recommendations.
key words
Cannabis; Marijuana use; Sudden infant death; Infant health
Thumbnail
